# Single Ascending Dose Study With 5-MeO-DMT in Healthy Subjects

> **NCT05032833** · PHASE1 · COMPLETED · sponsor: **Beckley Psytech Limited** · enrollment: 36 (actual)

## Conditions studied

- Pharmacokinetics in Healthy Adults

## Interventions

- **DRUG:** 5-MeO-DMT
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05032833
- **Lead sponsor:** Beckley Psytech Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-22
- **Primary completion:** 2022-07-07
- **Final completion:** 2022-07-07
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2022-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05032833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05032833, "Single Ascending Dose Study With 5-MeO-DMT in Healthy Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05032833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*